N
Nanjing Well Pharmaceutical Co Ltd
SSE:603351
Nanjing Well Pharmaceutical Co Ltd
SSE:603351
Price:
27.58
CNY
0.29%
Market Closed
Market Cap:
¥3.7B
Relative Value
The Relative Value of one Nanjing Well Pharmaceutical Co Ltd stock under the Base Case scenario is 30.8 CNY. Compared to the current market price of 27.58 CNY, Nanjing Well Pharmaceutical Co Ltd is Undervalued by 10%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
30.8
CNY
Undervaluation 10%
N
Multiples Across Competitors
Competitors Multiples
Nanjing Well Pharmaceutical Co Ltd Competitors
Nanjing Well Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
N
|
Nanjing Well Pharmaceutical Co Ltd
SSE:603351
|
3.7B CNY | 2.8 | 25.3 | 21.6 | 21.6 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | 1.6 | -33.9 | 11.5 | 68.3 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | 8.1 | 25.7 | 189.4 | 189.4 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
612T IDR | 6.5 | 20.6 | 152.5 | 152.5 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
169.3B CNY | 0.8 | 24.3 | 21.4 | 21.4 | |
| US |
|
Dow Inc
NYSE:DOW
|
21.7B USD | 0.5 | -19 | 10.3 | 66.6 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
132B CNY | 0.4 | 179.3 | 31.1 | 31.1 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
590.8B TWD | 2.2 | -5 430.2 | 26.5 | 307.2 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
17.4B USD | 0.5 | -14.4 | 10.2 | 22.3 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
23.7T KRW | 0.5 | -16 | 6.2 | 29.9 | |
| KR |
|
Ecopro Co Ltd
KOSDAQ:086520
|
22.5T KRW | 6.7 | -1 121.3 | 368.6 | 368.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
